Sebastien Corre
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.
Journal: Cell death discovery
Published: September 03, 2025
AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma.
Journal: Cell death discovery
Published: September 03, 2025
CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia.
Journal: Oncogenesis
Published: July 25, 2025
Cirscan: a shiny application to identify differentially active sponge mechanisms and visualize circRNA-miRNA-mRNA networks.
Journal: BMC bioinformatics
Published: October 26, 2023
The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.
Journal: EMBO molecular medicine
Published: January 04, 2022
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 08, 2021
AhR and Cancer: From Gene Profiling to Targeted Therapy.
Journal: International journal of molecular sciences
Published: November 06, 2020
CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and resistance.
Journal: EMBO molecular medicine
Published: September 16, 2020
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors.
Journal: International journal of molecular sciences
Published: June 02, 2020
Human TYRP1: Two functions for a single gene?
Journal: Pigment cell & melanoma research
Published: May 25, 2020
Last Updated: 09/26/2026